Pascual A - Search Results

1

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study.

Casanova B, Coret F, Valero C, Landete L, Pascual A, Vilchez JJ. Casanova B, et al. Among authors: pascual a. Mult Scler. 2002 Feb;8(1):59-63. doi: 10.1191/1352458502ms773oa. Mult Scler. 2002. PMID: 11939173

2

Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon.

Bosca I, Coret F, Valero C, Pascual AM, Magraner MJ, Landete L, Casanova B. Bosca I, et al. Among authors: pascual am. Mult Scler. 2008 Jun;14(5):636-9. doi: 10.1177/1352458507086666. Mult Scler. 2008. PMID: 18566027 Clinical Trial.

3

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.

Pascual AM, Téllez N, Boscá I, Mallada J, Belenguer A, Abellán I, Sempere AP, Fernández P, Magraner MJ, Coret F, Sanz MA, Montalbán X, Casanova B. Pascual AM, et al. Mult Scler. 2009 Nov;15(11):1303-10. doi: 10.1177/1352458509107015. Epub 2009 Oct 13. Mult Scler. 2009. PMID: 19825889

4

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study.

Casanova B, Martínez-Bisbal MC, Valero C, Celda B, Martí-Bonmatí L, Pascual A, Landente L, Coret F. Casanova B, et al. Among authors: pascual a. J Neurol. 2003 Jan;250(1):22-8. doi: 10.1007/s00415-003-0928-0. J Neurol. 2003. PMID: 12527988

5

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.

Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B. Pascual AM, et al. Neurology. 2007 Jul 3;69(1):63-7. doi: 10.1212/01.wnl.0000265054.08610.12. Neurology. 2007. PMID: 17606882

6

[Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].

Pascual AM, Boscá I, Escutia M, Bernat A, Coret F, Casanova B. Pascual AM, et al. Neurologia. 2008 Mar;23(2):73-7. Neurologia. 2008. PMID: 17641984 Clinical Trial. Spanish.

7

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale.

Pascual AM, Boscá I, Coret F, Escutia M, Bernat A, Casanova B. Pascual AM, et al. Eur J Neurol. 2008 Mar;15(3):284-8. doi: 10.1111/j.1468-1331.2008.02061.x. Eur J Neurol. 2008. PMID: 18290849 Clinical Trial.

8

Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis.

Casanova B, Bosca I, Parra S, Pascual A, Coret F. Casanova B, et al. Among authors: pascual a. Mult Scler. 2006 Aug;12(4):521-2. doi: 10.1191/135248506ms1351xx. Mult Scler. 2006. PMID: 16900770 No abstract available.

9

Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.

Bosca I, Pascual AM, Casanova B, Coret F, Sanz MA. Bosca I, et al. Among authors: pascual am. Neurology. 2008 Aug 5;71(6):457-8. doi: 10.1212/01.wnl.0000324422.69067.e7. Neurology. 2008. PMID: 18678830 No abstract available.

10

Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate.

Pascual AM, Coret F, Casanova B, Láinez MJ. Pascual AM, et al. J Neurol Sci. 2008 Apr 15;267(1-2):158-61. doi: 10.1016/j.jns.2007.09.035. Epub 2007 Oct 18. J Neurol Sci. 2008. PMID: 17949753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,050 results

Search Page

Filters